Comparisons in baseline and 10-year prognosis between acute onset and nonacute onset in each categorical group.

<p>#: Chi-square test, ^□: ANCOVA, $: ANOVA <i>abbreviations</i>: y = years; m = months; d = days; number in parentheses indicates standard deviation.</p

Change in the GAF from treatment intervention to 10-year follow-up point in the 4 subgroups.

<p>A)*<i>P</i><.05 by ANCOVA, indicating lesser increase of GAF in the NonSC-nonacute-group than those in the SC-acute and SC-nonacute groups. # <i>P</i><.05, indicating significant difference in DUP between the two groups. $ <i>P</i><.05 by ANOVA, indicating a lower baseline GAF in the SC group than in the NonSC group. B) This table shows the same data as A), particular for DUP and GAF changes of participants, to support understanding of the manuscript and A). *<i>P</i><.05 by ANCOVA. C) Comparison in GAF changes between the acute onset and nonacute onset groups. *<i>P</i><.05 by ANCOVA.</p

Clinical characteristics at admission.

<p><b>a</b>: Rate of the number of patients with 5 or greater points in at least one positive symptoms item within disorganization, suspiciousness, delusion and unusual thought content, among each group.</p><p><b>b</b>: Rate of the number of patients with 5 or greater points in excitement item among each group.</p><p><b>c</b>: Number of patients who required sedation by injected drugs, including haloperidol and/or fulnitrazepam.</p><p>#: Chi-square test, ^□: Student t-test, <i>abbreviations</i>: y = years; m = months; number in parentheses indicates standard deviation.</p